openPR Logo
Press release

Anti-PCSK9 Monoclonal Antibody Market: 2022 Analysis, Share, Trends, and Overview 2022-2028

04-25-2022 07:43 AM CET | Health & Medicine

Press release from: Orion Market Reports

The global anti-PCSK9 monoclonal antibody market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Monoclonal antibodies are immune system proteins that are directed towards a specific antigen in the body. Monoclonal antibodies are utilized for diagnostic and therapeutic purposes in immunotherapy. PCSK9 stands for proprotein convertase subtilisin/Kexin type-9, a serine protease that belongs to the subtilisin family. The anti-PCSK9 monoclonal antibody market is primarily driven by rising obesity rates globally, increased junk food consumption, and a lack of regular exercise. Moreover, an increasing number of individuals suffering from primary hypercholesterolemia and atherosclerotic cardiovascular disease is also significantly supporting the growth of the market.

(Get 15% Discount on Buying this Report)
Get Sample Copy of Anti-PCSK9 Monoclonal Antibody Market at:

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, in order to stay competitive in the market. For instance-

• In November 2021, MK-0616, a novel PCSK9 inhibitor under investigation had cleared clinical trials, with early evidence revealing LDL cholesterol reductions even in people on statins. MK-0616 is a PCSK9 inhibitor that is orally bioavailable and has nonclinical pharmacokinetic and safety features that justify a clinical trial.

• In August 2020, Hamad Medical Corp. studied PCSK9 monoclonal antibodies as a standalone therapeutic agent or as an add-on therapy to standard LLT for the treatment of dyslipidemia. They were found to be efficacious and safe in treating familial and non-familial hypercholesterolemia.

• In March 2020, Sanofi and Regeneron Pharmaceuticals, Inc., announced that a clinical trial for Kevzara (sarilumab) in patients hospitalized with severe COVID-19 infection has begun. Kevzara is a completely human monoclonal antibody that binds to and blocks the IL-6 receptor, inhibiting the interleukin-6 (IL-6) pathway.

• In March 2019, Innovent Biologics, Inc. (Innovent) announced that the first patient in a Phase-II clinical study of IBI306, a recombinant fully human anti-proprotein convertase substilisin/kexin type-9 (anti-PCSK9) monoclonal antibody for the treatment of hypercholesterolemia, has been dosed successfully.

A full report of Global Anti-PCSK9 Monoclonal Antibody Market is available at:

Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application

• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World

• Competitive Landscape- Sanofi S.A., Regeneron Pharmaceuticals, Inc., Amgen Inc., Thermo Fisher Scientific, and Abnova Corp., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anti-PCSK9 Monoclonal Antibody Market Report by Segment

By Type
• Alizumab
• Evolocumab

By Application
• Hypercholesterolemia
• Atherosclerotic Cardiovascular Disease
• Others

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-PCSK9 Monoclonal Antibody Market: 2022 Analysis, Share, Trends, and Overview 2022-2028 here

News-ID: 2610175 • Views: 338

More Releases from Orion Market Reports

Composites Market to Signify Strong Growth by 2023-2029
Composites Market to Signify Strong Growth by 2023-2029
The Composites Market size is expected to grow at an annual average of CAGR 7% during the forecast period (2023-2029). Composites are increasingly used in the aerospace industry as they decrease weight and increase fuel efficiency. The capability of aerospace composites to maintain a greater strength-to-weight ratio allows for more efficient structural and aerodynamic designs. There has been a paradigm shift in aircraft design at Boeing and Airbus, with aerospace
Polymeric Adsorbents Market Is Likely to Experience a Tremendous Growth by 2029
Polymeric Adsorbents Market Is Likely to Experience a Tremendous Growth by 2029
The Polymeric Adsorbents Market size is expected to grow at an annual average of CAGR 5% during the forecast period (2023-2029). Polymeric adsorbents are polymer beads mainly made of polystyrene with amine groups to form anion exchangers or sulfonate groups to develop cation exchangers. Polymeric adsorbents can extract components without any contamination efficiently compared to other adsorbents. Also, they are highly resistant to caustic and acidic conditions. Important changes in the
Adsorbents Market to Witness Growth Acceleration by 2029
Adsorbents Market to Witness Growth Acceleration by 2029
The Adsorbents Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2023-2029). Adsorbents are substances that can extract specific elements from solids, liquids, and gases while retaining their physical properties. They form layers through the adhesion process and are primarily used in the form of rods, monoliths, and molding, among other things. Adsorbents have a variety of properties, including high abrasion resistance,
Biocatalysis & Biocatalysts Market Booming Worldwide with Latest Trend and Future Scope by 2029
Biocatalysis & Biocatalysts Market Booming Worldwide with Latest Trend and Futur …
The Biocatalysis & Biocatalysts Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2023-2029). Biocatalysts are widely used in the food and beverage industry since several years as food enzymes for instance in dairy products, bakery, and beverages. Biocatalysts may be of different types and are used in various applications. Protease and amylases are widely used to remove food related stains. These

All 5 Releases

More Releases for PCSK9

PCSK9 Inhibitors Market to Eyewitness Stunning Growth by 2027 | Roche, Sanofi
This PCSK9 Inhibitors market report contains details about the industrial environment, market segmentation, channel characteristics and sourcing situation. From complex classifications, layouts, and purposes to a simple overview of the sector, this market research report covers it all. One of the most essential things to keep in mind in order to thrive in this competitive industry is to have a firm grasp on the business strategy that emerges. This PCSK9
Anti-PCSK9 Monoclonal Antibody Market Research Report (2021-2027): Key Trends an …
Los Angeles, United State, February 2021, – – QY Research offers an overarching research and analysis-based study on the global Anti-PCSK9 Monoclonal Antibody market, covering growth prospects, market development potential, profitability, supply and demand, and other important subjects. The report presented here comes out as a highly reliable source of information and data on the global Anti-PCSK9 Monoclonal Antibody market. The researchers and analysts who have prepared the report used
Global Anti-PCSK9 Monoclonal Antibody Market to Witness a Pronounce Growth Durin …
LP INFORMATION recently released a research report on the Anti-PCSK9 Monoclonal Antibody market analysis, which studies the Anti-PCSK9 Monoclonal Antibody's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Anti-PCSK9 Monoclonal Antibody Market 2020-2025” Research Report categorizes the global Anti-PCSK9 Monoclonal Antibody market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players
Global Anti-PCSK9 Monoclonal Antibody Sales, Revenue and Market Share by Manufac …
This report also researches and evaluates the impact of Covid-19 outbreak on the Anti-PCSK9 Monoclonal Antibody industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Anti-PCSK9 Monoclonal Antibody and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).   Scope of the Report: The report presents the market outlook for the Indian Phospho Gypsum product from the year 2020 to the year 2025. The
Global PCSK9 Inhibitors Market 2020 Amgen, Eli Lilly, Sanofi, Pfizer, Novartis, …
The report "Global PCSK9 Inhibitors Market" evaluates the present and future market opportunities of PCSK9 Inhibitors business. The analysis study sheds lightweight on a number of the main drivers and restraints factors influencing the expansion of the PCSK9 Inhibitors market. The market is separate on the idea of product sort, PCSK9 Inhibitors makers, application, and countries. practicableness of investment study, PCSK9 Inhibitors market standing from 2015 to 2020, PCSK9 Inhibitors
PCSK9 Inhibitors Sales Market to 2017 Industry Size, Share, Revenue Analysis 201 …
Worldwide Market Reports added Latest Research Report titled “PCSK9 Inhibitors Sales Market by Manufacturers, Regions, Product Type and Application, Forecast to 2025” to its Large Report database. PCSK9 Inhibitors Sales Market Report provides important information related to the overall market and price forecast over a five-year period, from 2017 to 2025. In this bit, the experts have offered essential figures which relates to the production and consumption forecast for the major